Toshiba America Medical Systems has received U.S. Food and Drug Administration (FDA) clearance for a new package of detector and software enhancements to its Aquilion One family of CT systems.
The version 7.0 package includes the following:
- AIDR 3D Enhanced, Toshiba's fourth-generation adaptive iterative dose reduction algorithm
- Its PureVision CT detector, with 40% better light output for improved use of x-ray photons
- SurekV automated kV selection based on patient size
- Organ effective modulation, which limits dose to radiosensitive organs and also during helical scanning and CT fluoroscopy procedures
- Contrast management features that improve workflow and safety by standardizing contrast protocols and automatically tracking volume of contrast used during an exam
- A power save mode that includes a sleep mode option for when the CT system is not in use
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)
